Future Directions in Chronic GvHD
Dr. Chaudhary and Dr. Merin discuss potential areas for exploration and unmet needs in the chronic GvHD treatment landscape.
EP: 1.The Chronic GvHD Landscape: Risk Factors and Diagnosis
EP: 2.First-line Treatment for Patients with Chronic GvHD
EP: 3.Defining and Managing Steroid Refractory Chronic GvHD
EP: 4.Role of Ruxolitinib in Steroid-Refractory Chronic GvHD
EP: 5.Understanding Mechanisms of Action: Ruxolitinib, Ibrutinib, and Belumosudil
EP: 6.Key Efficacy Data of Ibrutinib and Belumosudil in Steroid-Refractory Chronic GvHD Patients
EP: 7.Real World Data on the Use of Ruxolitinib and Treatment Selection in chronic GvHD
Now Viewing
EP: 8.Future Directions in Chronic GvHD
Related Videos
Related Content
%201%20(1)%20copy.jpg?fit=crop&auto=format)
